| Ticker | ALKS |
|---|---|
| ISIN | IE00B56GVS15 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; VIVITROL for the treatment of alcohol and prevention of opioid dependence; RISPERDAL CONSTA for the treatment of schizophrenia and bipolar I disorder;...
El precio actual de Alkermes PLC. (ALKS) es de 33,31 , con una variación del -1,77%.
Alkermes PLC. opera en el sector Healthcare, industria Biotechnology.